期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL BIOCHEMISTRY LetPub Score 6.5
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 9.2 | ||||||||||||||||
期刊簡稱 | CLIN BIOCHEM | ||||||||||||||||
ISSN | 0009-9120 | ||||||||||||||||
E-ISSN | 1873-2933 | ||||||||||||||||
h-index | 100 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 4.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.journals.elsevier.com/clinical-biochemistry/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CLB | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier Inc. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | CANADA | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1967 | ||||||||||||||||
每年文章數 | 158每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 18.62% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-9120%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Fast, 2-4 Week(s) 來自Elsevier的數據: Average 5.3 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 15.6 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[CLINICAL BIOCHEMISTRY] 的評論 | 撰寫評論 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-09 18:34:01 評論於 Not required(0) 讚! | 月河溪蓝 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-09 11:46:05 評論於 It doesn't matter if you choose OA or not. The electronic version will be available one week after acceptance, and the official publication will be two months later(0) 讚! | 月河溪蓝 |
作者: 雾都驰海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-17 20:42:20 評論於 Hello, does every co-author need to confirm the submission?(0) 讚! | 雾都驰海 |
作者: 雾都驰海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-17 15:35:18 評論於 Hello, does every co-author need to confirm the submission?(0) 讚! | 雾都驰海 |
作者: 雾都驰海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-17 12:55:53 評論於 Hello, do we need confirmation from each co-author for submission?(0) 讚! | 雾都驰海 |
作者: 雾都驰海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-17 09:02:30 評論於 Hello, do we need confirmation from each co-author before submission?(0) 讚! | 雾都驰海 |
作者: 仙灵听莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-10 08:22:28 評論於 Hello, do you know the email address of the editorial department?(0) 讚! | 仙灵听莲 |
作者: 北岳傲菡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-07 08:52:26 評論於 If the non-OA option is chosen, how long does it typically take for acceptance to publication? Thank you(0) 讚! | 北岳傲菡 |
作者: 仙灵听莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-03 22:58:54 評論於 Please provide the email address for the magazine editor. Thank you, everyone!(0) 讚! | 仙灵听莲 |
作者: 仙灵听莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-03 10:29:36 評論於 Hello, may I ask if there is an editorial department email? Thank you very much!(0) 讚! | 仙灵听莲 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-23 14:18:49 評論於 Take a closer look and register easily(0) 讚! | 月河溪蓝 |
作者: 纯阳宛白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-08 14:52:56 評論於 Why can't I register?(0) 讚! | 纯阳宛白 |
作者: 北风红芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-19 19:33:05 評論於 Thank you, master(0) 讚! | 北风红芹 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-02 18:30:23 評論於 You can choose not to have ads, do not charge for layout fees(0) 讚! | 月河溪蓝 |
作者: 北风红芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-27 11:38:50 評論於 How much is the layout fee?(0) 讚! | 北风红芹 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-14 12:54:54 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Emphasized research directions: testing; biomarkers; sharing of clinical testing experiences: submit 11.21 with editor 11.23 under review 12.02 required reviews completed 12.22 major revision 1.3 resubmit 1.19 under review 1.19 minor revision and modification 1.26 resubmit 2.6 under review 2.8 accept 2.21 A very friendly journal, with fast review process and very friendly reviewers(0) 讚! | 月河溪蓝 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-16 10:12:24 評論於 Thank you and I wish you continued success(0) 讚! | 月河溪蓝 |
作者: 月河溪蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-15 23:39:44 評論於 Hello, could you please tell me if the reviewers are friendly? I am currently revising a major article and would like to seek some advice(0) 讚! | 月河溪蓝 |
作者: 飞龙瑛琭 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-15 08:41:11 評論於 The reviewers are quite friendly, as long as you answer the questions seriously(0) 讚! | 飞龙瑛琭 |
作者: 飞龙瑛琭 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-02 13:35:34 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Emphasized research direction: biomarkers; Clinical experience sharing: 10.8 submit 11.12 review completed 11.15 major 12.11 resubmit 12.29 review completed 1.3 minor 1.5 resubmit 1.7 accept(0) 讚! | 飞龙瑛琭 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:00:02 評論於 "I love traveling to different countries and experiencing new cultures. It's amazing to see how diverse our world can be."(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:16:47 評論於 The discussion section is the core part of a SCI paper, as it reflects the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Different articles by different authors may vary in length, ranging from several thousand to several tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 09:33:33 評論於 Can experiments that were planned but not carried out be included in the discussion?(0) 讚! | 深渊兴业 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 21:48:05 評論於 How many words should be kept in a general discussion?(0) 讚! | 北国博达 |
作者: 无冬智阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-23 12:46:07 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Emphasis on research direction: empirical testing and sharing experiences: I made 3 revisions and it was accepted today. Thank you for your support and gratitude(0) 讚! | 无冬智阳 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us